Mimeault M - Search Results

1

Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Mimeault M, Batra SK. Mimeault M, et al. J Cell Mol Med. 2013 Jan;17(1):30-54. doi: 10.1111/jcmm.12004. Epub 2013 Jan 10. J Cell Mol Med. 2013. PMID: 23301832 Free PMC article.

2

Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Ann Oncol. 2007 Oct;18(10):1605-19. doi: 10.1093/annonc/mdm070. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355951 Free article. Review.

3

Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.

Mimeault M, Hauke R, Mehta PP, Batra SK. Mimeault M, et al. J Cell Mol Med. 2007 Sep-Oct;11(5):981-1011. doi: 10.1111/j.1582-4934.2007.00088.x. J Cell Mol Med. 2007. PMID: 17979879 Free PMC article. Review.

4

Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Mimeault M, Batra SK. Mimeault M, et al. Panminerva Med. 2008 Mar;50(1):3-18. Panminerva Med. 2008. PMID: 18427384 Free PMC article. Review.

5

Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.

Mimeault M, Batra SK. Mimeault M, et al. Gut. 2008 Oct;57(10):1456-68. doi: 10.1136/gut.2008.150052. Gut. 2008. PMID: 18791122 Free PMC article. Review.

6

New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.

Mimeault M, Batra SK. Mimeault M, et al. Histol Histopathol. 2010 Aug;25(8):1057-73. doi: 10.14670/HH-25.1057. Histol Histopathol. 2010. PMID: 20552555 Free PMC article. Review.

7

Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.

Mimeault M, Johansson SL, Batra SK. Mimeault M, et al. Br J Cancer. 2013 Mar 19;108(5):1079-91. doi: 10.1038/bjc.2012.484. Epub 2013 Feb 28. Br J Cancer. 2013. PMID: 23449353 Free PMC article.

8

Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Stem Cells. 2006 Nov;24(11):2319-45. doi: 10.1634/stemcells.2006-0066. Epub 2006 Jun 22. Stem Cells. 2006. PMID: 16794264 Review.

9

Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.

Mimeault M, Batra SK. Mimeault M, et al. Cancer Metastasis Rev. 2007 Mar;26(1):203-14. doi: 10.1007/s10555-007-9052-4. Cancer Metastasis Rev. 2007. PMID: 17273942 Review.

10

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.

Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Mol Cancer Ther. 2007 Mar;6(3):967-78. doi: 10.1158/1535-7163.MCT-06-0648. Mol Cancer Ther. 2007. PMID: 17363490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters